Progressive myopia

Tokyo Medical and Dental University (TMDU) will introduce the Eyerising Myopia Management Device for its myopia patients as part of...

ZEISS has formed a new Myopia Advisory Board, a think-tank of leading experts – including three Australians – whose scientific...

Stellest lenses demonstrated significant myopia control in their original two-year clinical trial. After extending the study for another two years,...

At the completion of this article, the reader should be able to improve their management of progressive myopia with atropine,...

  Australian medical device company Eyerising International says its device has been “misrepresented” in a recent study over the safety...

  As students return to classrooms across Australia, lens manufacturer HOYA is urging optometrists, parents and educators to prioritise discussions...

Myopia dominated the clinical program at O=MEGA23 and the 4th World Congress of Optometry, but there were also many other...

Australian hyperparallel OCT (HP-OCT) manufacturer Cylite has entered an agreement to integrate the recently launched PreMO myopia app into its...

Visioneering Technologies Inc (VTI) has announced positive interim one-year data from the PROTECT clinical trial of its paediatric myopia progression...

Eyerising International has addressed questions over the safety of its repeated-low level red-Light (RLRL) treatment for myopia management, following two...